COYA — Coya Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- $97.82m
- $50.99m
- $7.95m
Annual balance sheet for Coya Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 4.34 | 5.93 | 32.6 | 38.3 | 46.8 |
| Net Total Receivables | 0 | — | 7.5 | 0.731 | — |
| Prepaid Expenses | |||||
| Total Current Assets | 4.58 | 7.18 | 41.2 | 44.3 | 49.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.121 | 0.093 | 0.066 | 0.039 | 0.011 |
| Other Long Term Assets | |||||
| Total Assets | 4.79 | 8.4 | 41.3 | 44.3 | 50 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.15 | 3.82 | 5.05 | 3.82 | 5.87 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.15 | 16.8 | 5.63 | 4.77 | 6.92 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 3.64 | -8.39 | 35.6 | 39.6 | 43 |
| Total Liabilities & Shareholders' Equity | 4.79 | 8.4 | 41.3 | 44.3 | 50 |
| Total Common Shares Outstanding |